MXPA03006477A - Metodo de tratamiento de diabetes tipo i. - Google Patents

Metodo de tratamiento de diabetes tipo i.

Info

Publication number
MXPA03006477A
MXPA03006477A MXPA03006477A MXPA03006477A MXPA03006477A MX PA03006477 A MXPA03006477 A MX PA03006477A MX PA03006477 A MXPA03006477 A MX PA03006477A MX PA03006477 A MXPA03006477 A MX PA03006477A MX PA03006477 A MXPA03006477 A MX PA03006477A
Authority
MX
Mexico
Prior art keywords
diabetes
treatment
type
onset
human patient
Prior art date
Application number
MXPA03006477A
Other languages
English (en)
Inventor
Mccary Laura
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of MXPA03006477A publication Critical patent/MXPA03006477A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00—Technologies related to metal processing
    • Y02P10/25—Process efficiency

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a un metodo para retrasar el surgimiento o reducir la gravedad de la diabetes en un paciente humano. En una modalidad, la presente invencion comprende el paso de administrarle por via oral al paciente humano una cantidad efectiva de un compuesto de vitamina D, de tal modo que el surgimiento de la diabetes sea mas lento o los sintomas se reduzcan.
MXPA03006477A 2001-01-25 2001-12-27 Metodo de tratamiento de diabetes tipo i. MXPA03006477A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/769,579 US20030018017A1 (en) 2001-01-25 2001-01-25 Method of treatment of type I diabetes
PCT/US2001/049631 WO2002058707A2 (en) 2001-01-25 2001-12-27 Method of treatment of type i diabetes with vitamin d compounds

Publications (1)

Publication Number Publication Date
MXPA03006477A true MXPA03006477A (es) 2004-05-24

Family

ID=25085878

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006477A MXPA03006477A (es) 2001-01-25 2001-12-27 Metodo de tratamiento de diabetes tipo i.

Country Status (8)

Country Link
US (1) US20030018017A1 (es)
EP (1) EP1353677A2 (es)
JP (1) JP2005503996A (es)
CN (1) CN1551776A (es)
CA (1) CA2434929A1 (es)
IS (1) IS6888A (es)
MX (1) MXPA03006477A (es)
WO (1) WO2002058707A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060079490A1 (en) * 2001-01-25 2006-04-13 Deluca Hector F Method of treatment of type I diabetes
WO2008035228A2 (en) 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
JP2009532457A (ja) 2006-04-06 2009-09-10 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−１α−ヒドロキシ−１８，１９，２１−トリノルビタミンＤ３類縁体およびその使用
JP2010505739A (ja) * 2006-04-06 2010-02-25 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−１α，２５−ジヒドロキシ−１９，２１−ジノルビタミンＤ３類縁体およびその使用
JP2009532459A (ja) 2006-04-06 2009-09-10 ウイスコンシン アラムニ リサーチ ファンデーション １，２または３，２複素環を有する１９−ノル−ビタミンｄアナログ
AU2007298652A1 (en) 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1alpha-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof
MX2008012913A (es) 2006-04-06 2009-03-06 Wisconsin Alumni Res Found 2-metilen-1a,25-dihidroxi-18,19,21-trinorvitamina d3 y sus usos.
AU2007287263A1 (en) 2006-04-10 2008-02-28 Wisconsin Alumni Research Foundation Lalpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-nor- vitamin D compounds with a 1,1-dimethylpropyl side chain
CN109125348A (zh) * 2018-08-27 2019-01-04 杭州荣泽生物科技有限公司 脐带充质干细胞联合维生素d在治疗糖尿病药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904154D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5665387A (en) * 1994-09-01 1997-09-09 K.U. Leuven Research & Development Methods and compositions for primary and secondary prevention of autoimmune diabetes
FR2735367B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Utilisation de ligands specifiques des recepteurs rxrs
ATE399151T1 (de) * 2000-05-31 2008-07-15 Wisconsin Alumni Res Found 2-ethyl und 2-ethyliden-19-nor-vitamin d- verbindungen

Also Published As

Publication number Publication date
WO2002058707A3 (en) 2003-04-17
US20030018017A1 (en) 2003-01-23
EP1353677A2 (en) 2003-10-22
WO2002058707A2 (en) 2002-08-01
IS6888A (is) 2003-07-24
CA2434929A1 (en) 2002-08-01
CN1551776A (zh) 2004-12-01
JP2005503996A (ja) 2005-02-10

Similar Documents

Publication Publication Date Title
MXPA04006039A (es) Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
NO20052348L (no) Behandling av hemoragisk sjokk
GB0109146D0 (en) Treatment of type 2 diabetes
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
AU2003297048A1 (en) Cyclohexyl compounds as ccr5 antagonists
WO2003024391A3 (en) Treatment and prevention of mucositis in cancer patients
AU2003296992A1 (en) Pyrrolidine and azetidine compounds as ccr5 antagonists
AU2002352531A1 (en) Use of at least one glycoinhibitor substance
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2003082260A3 (en) Tuberculosis treatment using pleuromutilin derivatives
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
MXPA03006477A (es) Metodo de tratamiento de diabetes tipo i.
CO5251468A1 (es) Metodo para el tratamiento de insuficiencias venosas cronicas utilizando un extracto de hojas de vid roja
WO2004110392A3 (en) Compositions and methods for treating coronavirus infection and sars
WO2006136428A3 (en) Method and composition to treat skin ulcers
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
MXPA05001469A (es) Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.
WO2004087880A3 (en) Compounds and their use to treat diabetes and related disorders
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
YU11904A (sh) Upotreba inhibitora il-18 kod poremećaja preosetljivosti
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2003075900A3 (de) Verwendung von ubichinonen zur beeinflussung der histaminwirkung zur behandlung von bronchitis, asthma, allergischen krankheiten
AP2004003113A0 (en) Use of an inhibitor or antagonist against tissue factor
ITRM20010494A1 (it) Integratore dietetico per la cura e la prevenzione della miopia.
WO2004002486A3 (en) Ciprofloxacin hci